SB-462795 does not exhibit difference of serum osteocalcin (a biomarker of osteoblast activity) between SB-462795 and vehicle treated animalsexcept for the 48 h time point where a significant reduction (42% lower than baseline vs
is also a small molecule Polo-like kinase 1 (PLK1) inhibitor with potential antineoplastic activity
The results suggest that BXA has both potent and broad activity against influenza A and B viruses compared to the other marketed drugs
5(11):677-692
and is antagonized by overexpression of POT1 or TRF2
Olmesartan-d6 Acid Size:Contact [email protected] for quotation SB-462795 does not exhibit differenceProduct information CAS Number: 1185144 74 4 Molecular Weight: 452. 54 Formula: C24H26N6O3 Chemical Name: 4 [2 hydroxy(1,1,1,3,3,3 H)propan 2 yl] 2 propyl 1 {[2' (2H 1,2,3,4 tetrazol 5 yl) [1,1' biphenyl] 4 yl]methyl} 1H imidazole 5 carboxylic acid Smiles: [2H]C([2H])([2H])C(O)(C1N=C(CCC)N(CC2C=CC(=CC=2)C2=CC=CC=C2C2=NNN=N2)C=1C(O)=O)C([2H])([2H])[2H] InChiKey: VTRAEEWXHOVJFV XERRXZQWSA N InChi: InChI=1S C24H26N6O3 c1 4 7 19 25